HIGHLIGHTS
- who: Paul J. Hengeveld from the DepartmentUniversity Medical have published the Article: Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110, in the Journal: (JOURNAL) of 18/03/2022
- what: Taken together, in the study , the authors have characterized the clinicobiological features of the largest cohort of IGLV3-21R110 patients (n=48) reported thus far. The authors demonstrate that CLL with the IGLV3-21R110 is typified by a distinct molecular profile.
- how: These observations require further validation in a larger series as the number of IGLV3-21R110 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.